Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Bosutinib: Pediatric first approval (Hoy SM et al. Paediatr Drugs, Dec 2023)

Bosutinib: Pediatric first approval - Review
Hoy SM. Paediatr Drugs, December 2023 (epub ahead of print)

Link to full abstract


 

 

 

 

Skin reactions to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia (Toker M et al. Pediatr Dermatol, Dec 2023)

Skin reactions to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia - Review
Toker M et al. Pediatr Dermatol, December 2023 (epub ahead of print)
 
Link to full abstract


 

 

 

 

Chronic myeloid leukemia (CML) in children and adolescents - Clinicopathological findings (Nevejan L et al. Eur J Haematol, Nov 2023)

Chronic myeloid leukemia (CML) in children and adolescents – Clinicopathological findings
Nevejan L et al. Eur J Haematol, November 2023 (epub ahead of print)

Link to full abstract


 

 

 

 

Treatment and follow-up of children with CML-CP in the TKI era - Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort (Roy Moulik N et al. Br J Haematol, Dec 2023)

Treatment and follow-up of children with chronic myeloid leukemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era – Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort
Roy Moulik N et al. Br J Haematol, December 2023 (epub ahead of print)

Link to full abstract


 

 

 

 

Physiologically based pharmacokinetics modelling of nilotinib for drug-drug interactions, pediatric patients, and pregnancy and lactation (Liu XI et al. J Clin Pharmacol, Nov 2023)

Physiologically based pharmacokinetics modelling of nilotinib for drug-drug interactions, pediatric patients, and pregnancy and lactation
Liu XI et al. J Clin Pharmacol, November 2023 (epub ahead of print)

Link to full abstract


 

 

 

 

  1. Continuous therapy response references for BCR::ABL1 in pediatric chronic myeloid leukemia (Volz C et al. Sci Rep, Oct 2023)
  2. Somatic variant profiling in chronic phase pediatric CML (Behrens YL et al. Haematologica, Sept 2023)
  3. The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study (Hijiya N et al. Blood Adv, Sept 2023)
  4. Priapism at diagnosis of pediatric chronic myeloid leukemia: Data derived from a large cohort of children and teenagers and a narrative review on priapism management (Suttorp M et al. J Clin Med